Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient

Journal of Intensive Care

Volumn 5, Issue 1, 2017, Pages

  David, Sascha ^a   Thamm, Kristina ^a   Schmidt, Bernhard M W ^a   Falk, Christine S ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokines; Endothelial permeability; Extracorporeal removal; Sepsis; Vascular leakage

Indexed keywords

CATECHOLAMINE; CLINDAMYCIN; F ACTIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; INOTROPIC AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MEROPENEM; MONOCYTE CHEMOTACTIC PROTEIN 1; PIPERACILLIN; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR; UVOMORULIN; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ADJUVANT THERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTI-INFECTIVE THERAPY; ARTICLE; BLOOD FILTER; BLOOD VESSEL PERMEABILITY; CASE REPORT; CAUCASIAN; CELL CONTACT; CONTINUOUS HEMODIALYSIS; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; ESCHERICHIA COLI; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FEMALE; FEVER; FLUID RESUSCITATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTENSIVE CARE UNIT; MALAISE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; THERAPEUTIC CYTOKINE REMOVAL; TOXIC SHOCK SYNDROME; TRANSEPITHELIAL RESISTANCE; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 85010011057     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/s40560-017-0208-1     Document Type: Article

References (7)

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-10.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138-50.
3. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101(10):3765-77.
4. Lee WL, Slutsky AS. Sepsis and endothelial permeability. N Engl J Med. 2010;363(7):689-91.
5. David S, Mukherjee A, Ghosh CC, Yano M, Khankin EV, Wenger JB, Karumanchi SA, Shapiro NI, Parikh SM. Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis*. Crit Care Med. 2012;40(11):3034-41.
6. David S, Ghosh CC, Mukherjee A, Parikh SM. Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense. Arterioscler Thromb Vasc Biol. 2011;31(11):2643-52.
7. Bruenger F, Kizner L, Weile J, Morshuis M, Gummert JF. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015;38(2):113-6.